Parker Health
- Industry
- Biotechnology
- Founded Year
- 2019
- Headquarters
- Washington, DC and Dallas, TX
- Employee Count
- 25
Key People
- Vincent Lopez - Founder and CEO
- Anthony Lopez - Chief Financial Officer
- Chris Parker - Former Chief Technology Officer
- Phillip McDonald - Chief Medical Officer
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team has significant experience in healthcare and technology.
Vincent Lopez, the founder and CEO, has been recognized in Forbes' 30 Under 30, indicating notable achievements in the industry. The team includes experienced professionals in key roles, suggesting a strong foundation for the company's operations.
- Clinical Need
-
Aspect: Strong
Summary: The company's products address significant gaps in healthcare technology.
Parker Health's Health Management System aims to simplify healthcare complexities by unifying patient data and care delivery, addressing the need for more integrated and efficient healthcare solutions.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The market for healthcare management systems is highly competitive with established players.
The healthcare technology sector features numerous established companies offering similar solutions, making it challenging for new entrants to gain significant market share.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing a comprehensive health management system presents moderate technical challenges.
While creating an interoperable and compliant health management system is complex, existing technologies and standards like FHIR provide a framework that can be leveraged, reducing the overall technical risk.
- Patent
-
Aspect: Applied
Summary: The company has applied for patents but has limited granted intellectual property.
Parker Health has applied for patents related to its technologies, indicating a focus on protecting its innovations. However, the limited number of granted patents may affect its competitive edge.
- Financing
-
Aspect: Medium
Summary: The company has secured significant funding but faces challenges due to recent developments.
Parker Health raised $25 million in Series A funding led by Bias Capital. However, in February 2025, Bias Capital canceled this investment amid serious fraud concerns, which could impact the company's financial stability and future funding prospects.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products require regulatory approval, which is a standard process in the industry.
As a provider of healthcare technology solutions, Parker Health's products are subject to regulatory approvals such as 510(k) or PMA. While this is standard, navigating the regulatory landscape can be time-consuming and resource-intensive.
Opportunity Rollup
- Odds of Success
- 3.4
- Peak Market Share
- 4.6
- Segment CAGR
- 4.0%
- Market Segment
- Healthcare Technology
- Market Sub Segment
- Health Management Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.23 |
| 2 | 0.69 |
| 3 | 1.61 |
| 4 | 3.22 |
| 5 | 4.60 |
Key Takeaway
Parker Health offers innovative healthcare solutions but faces significant challenges due to market competition and recent financial developments.